Shares of XenoPort, Inc. XNPT were trading higher by nearly 6 percent at $5.07 early Friday morning.
Reuters reported late Thursday afternoon that the bio-pharmaceutical company is in the early stages of exploring a potential sale of itself.
Citing "people familiar with the matter," Reuters added that the XenoPort is working with investment bankers and has already reached out to potential acquirers to discuss a sale.
Shares of XenoPort have lost more than 40 percent over the past year.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in